PET, fMRI find psychopaths have higher dopamine levels
High dopamine levels are linked to a greater level of such psychopathic traits as manipulativeness, egocentricity, aggression, and risk-taking, a study by Vanderbilt University researchers has found.
High dopamine levels are linked to a greater level of such psychopathic traits as manipulativeness, egocentricity, aggression, and risk-taking, a study by Vanderbilt University researchers has found.
Using PET and fMRI studies, the researchers looked for changes in the dopamine reward circuitry. They also had all participants complete a personality inventory to assess their tendencies to psychopathic behavior.
After volunteers were given a dose of amphetamine, they were scanned with PET to measure dopamine release. Substance abuse has been shown in the past to be associated with alterations in dopamine responses; the researchers hypothesized that psychopathic traits were also linked to dysfunction in dopamine reward circuitry.
“Consistent with what we thought, we found people with high levels of psychopathic traits had almost four times the amount of dopamine released in response to amphetamine,” said Joshua Buckholtz, a graduate student in psychology and lead author of the study.
In the fMRI portion of the test, volunteers were scanned while told they would receive a monetary reward for completing a simple task. The dopamine reward area was more active in subjects with elevated psychopathic traits than in other volunteers while subjects anticipated the monetary reward.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
